Viewing Study NCT04347967


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-25 @ 10:49 PM
Study NCT ID: NCT04347967
Status: UNKNOWN
Last Update Posted: 2023-12-04
First Post: 2020-04-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)
Sponsor: Meridigen Biotech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module